{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-21-029110","form_type":"8-K","ticker":"TECH","cik":"0000842023","company_name":"BIO-TECHNE Corp","filed_at":"2021-12-22T23:59:59+00:00","discovered_at":"2026-05-14T18:04:15.816583+00:00","generated_at":"2026-06-27T23:07:32.630190+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Bio-Techne appoints Will Geist President, Protein Sciences Segment, succeeding retiring Dave Eansor","bullets":["Geist, former COO of Quanterix and former VP/GM at Thermo Fisher, appointed effective Jan 3, 2022.","He succeeds N. David Eansor, who will retire and assist transition through Feb 2022.","Base salary $500,000; target cash bonus 85%; annual equity grants ~$1.8M; one-time RSU grant $1M.","Geist has over 20 years senior life science tools experience; CEO highlighted his experience running >$1B revenue businesses."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-21-029110","json":"https://secwatch.observer/filing/0001437749-21-029110.json","markdown":"https://secwatch.observer/filing/0001437749-21-029110.md","text":"https://secwatch.observer/filing/0001437749-21-029110.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/842023/000143774921029110/0001437749-21-029110-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/842023/000143774921029110/tech20211222_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T23:07:32.630190+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0466a6229d","claim":"N. David Eansor departed as President, Protein Sciences Segment at BIO-TECHNE Corp.","evidence_excerpt":"Mr. Geist succeeds N. David Eansor, who has announced his intention to retire.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/842023/000143774921029110/0001437749-21-029110-index.htm","confidence":0.9,"family_label":"Executive change","details":[{"label":"Action","value":"announced intention to retire"},{"label":"Role","value":"President, Protein Sciences Segment"}],"fact_type":"executive_change"},{"claim_id":"94afa3b51d","claim":"William Alexander Geist was appointed as President, Protein Sciences Segment at BIO-TECHNE Corp.","evidence_excerpt":"On December 17, 2021, the Compensation Committee of the Board of Directors of Bio-Techne Corporation (the “Company”) appointed Mr. William Alexander Geist, age 52, as an executive officer of the Company in the position of President, Protein Sciences Segment, effective January 3, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/842023/000143774921029110/0001437749-21-029110-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"President, Protein Sciences Segment"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}